| Approved Brands: |
1. COBAN PREMIX contains monensin (as monensin sodium) at 200 g/kg
(Elanco)
2. RUMENSIN PREMIX contains monensin (as monensin sodium) at 200 g/kg (Elanco)
3. MONENSIN PREMIX contains monensin (as monensin sodium) at 200 g/kg (Bio Agri Mix
Limited) |
| Approved for use: |
In meal or pellet feed for broiler chickens, cattle and
turkeys.
In thixotrope liquid supplements for cattle (RUMENSIN PREMIX and COBAN PREMIX only and
must not be fed directly). |
| NOTE: |
Monensin Premix is approved only for claims 1, 2, 3, 4 & 5 |
| Approved claims: |
For broiler chickens - Claim 1
For turkeys - Claim 2
For beef cattle - Claim 3
For cattle - Claim 4
For pasture cattle - Claim 5
For lactating dairy cows - claims 6, 7, and 8 |
|
| Claim 1: |
As an aid in the prevention of coccidiosis in broiler
chickens caused by Eimeria necatrix, E. tenella, E. acervulina, E.
brunetti, E. mitis, and E. maxima. |
|
Level of Drug: |
99 mg/kg (0.0099%) of monensin activity in the complete feed. |
|
Directions: |
Feed this medicated feed as sole ration. |
|
WARNING: |
1. Do not feed to replacement or laying chickens. |
|
CAUTION: |
1. Do not use this medicated feed for treatment of outbreaks of
Coccidiosis.
2. Consult a veterinarian or poultry pathologist if losses exceed 0.5% in a 2 day period.
3. Do not allow dogs, horses, other equines, or guinea fowl access to formulations
containing monensin. Ingestion of monensin by these species has been fatal.
4. Poultry consuming monensin should not be treated with products containing tiamulin.
Severe growth depression may occur.
5. May be used in feeds containing the pellet binding agents Bentonite (2%), Attapulgite
(2%), Kaolin (2.5%), Lignin Sulfonate (4%), Carboxymethylcellulose (0.1%), or Agri-Colloid
(Premix and Supplement labels only).
|
| Claim 2: |
As an aid in the prevention of Coccidiosis in growing
turkeys caused by Eimeria adenoeides, E.meleagrimitis, and E.
gallapavonis. |
|
Level of Drug: |
99 mg/kg (0.0099%) of monensin activity, in the complete feed. |
|
Directions: |
Feed this medicated feed as the sole ration to growing turkeys of less than 10 weeks
of age. |
|
WARNING: |
1. Do not feed to replacement, laying or breeding turkeys. |
|
CAUTION: |
1. Do not use this medicated feed for treatment of outbreaks of
Coccidiosis.
2. Do not allow dogs, horses, other equines or guinea fowl access to formulations
containing monensin. Ingestions of monensin by these species has been fatal.
3. Poultry consuming monensin should not be treated with products containing tiamulin.
Severe growth depression may occur.
4. Do not feed to turkeys over 10 weeks of age.
5. Some species of turkey coccidia may be monensin-tolerant.
6. May be used in feeds containing the pellet-binding agents Bentonite (2%), Attapulgite
(2%), Kaolin (2.5%), Lignin Sulfonate (4%), Carboxymethylcellulose (0.1%), or Agri-Colloid
(Premix and supplement labels only). |
| Claim 3: |
For improved feed efficiency in beef cattle (steers and
heifers) fed in confinement for slaughter. |
|
Level of Drug: |
Chose one of the feeding programs provided below: |
|
Option 1: |
Day 0 to market weight:
Monensin activity 33 mg/kg (0.0033%) in the complete diet. |
|
Option 2: |
a) Introductory period of 28 days:
monensin activity 11 mg/kg (0.0011%) in the complete diet. b) Remainder
of feeding period to market weight:
monensin activity 33 mg/kg (0.0033%) in the complete diet |
|
NOTE: |
Complete diet refers to the complete feed plus the roughage and must be
corrected to a 100% dry matter basis. |
|
Directions for use: |
At a level in supplements, premixes, and complete feeds so that when used
as directed, the approved level of drug will be supplied. Thoroughly mix the
supplements and premixes in the total daily diet or in complete feed (grain portion of the
ration) before use. Do not feed undiluted.
Medicated supplement/premix fed as a % of total diet dry matter:
Mixing medicated supplements or premixes as a % of total diet dry matter is ideal. The
following calculation can be used to assist in determining the amount of monensin sodium
required per kg of supplement/premix dry matter to meet the approved level of drug in the
total diet dry matter;
mg monensin/kg supplement/premix dry matter = (approved drug level (mg/kg total diet
Dry Matter)) / (% inclusion of supplement/premix into diet on a 100% dry matter basis) x
100
Medicated supplement/premix fed as a fixed amount/head/day:
It may sometimes be preferable to mix the medicated supplement/premix in the complete feed
or total diet as a fixed amount/head/day. The approved levels of monensin sodium must be
converted to mg/head/day to accommodate this type of feeding. To do this, the following
calculation is used:
mg/head/day = weight of animal (kg) x dry matter intake (% of body weight) x approved
drug level (mg/kg total diet Dry Matter).
This calculation has been made for a wide range of body weights, using six different
dry matter intake levels and is presented in "Daily Intake of Monensin Activity"
tables found in the Rumensin Technical Reference Guide Addendum, or is available from the
manufacturer in the case of Monensin Premix.
Note that feed labels will be required to state both the body weight of the
cattle being fed as well as their dry matter intake.
Medicated complete feeds:
Medicated complete feeds are often fed separately from the forage part of the ration on a
fixed amount/head/day. The approved levels of monensin sodium must be converted to mg/head/day
to accommodate this type of feeding. To do this, the following calculation is used:
mg monensin/head/day = weight of animal (kg) x dry matter intake (as a % of body
weight) x approved drug level (mg/kg total diet Dry Matter).
Note that feed labels will be required to state both the body weight of the
cattle being fed as well as their dry matter intake. |
|
NOTE: |
Rumensin Premix and COBAN Premix only can be used in the following
thixotrope liquid supplements:
1) HCS, Nutrena Feeds, Cargill Limited;
2) Promolas Liquid Supplement Suspension, Westway Feed Products, a Division of
Westway Holdings Canada Inc. |
|
WARNING: |
1. Do not supplement monensin from other sources (eg. other feedstuffs
containing monensin or the Rumensin Controlled Release Capsule). |
|
CAUTION: |
1. Do not exceed recommended levels as reduced average daily gains may
result. 2. Do not allow dogs, horses, other equines or guinea fowl access to
formulations containing monensin. Ingestion of monensin by these species has been fatal.
3. Feed only to beef cattle (steers and heifers) intended for slaughter and maintained
under confinement.
4. May be used in feeds containing the pellet-binding agents Bentonite (2%),
Attapulgite (2%), Kaolin (2.5%), Lignin Sulfonate(4%), Carboxymethylcellulose (0.1%), or
Agri-Colloid. (Premix and supplement labels only).
5. Do not use thixotropic supplements after four weeks storage (Cargill thixotropic
liquid supplement labels only).
6. Do not use thixotropic supplements after eight weeks storage (Westway Feed Products,
A Division of Westway Holdings Canada Inc., thixotropic liquid supplement labels only). |
| Claim 4: |
As an aid in the prevention of Coccidiosis caused by Eimeria bovis and Eimeria zuernii in cattle. |
|
NOTE: |
Coccidiosis occurs sporadically in first lactation dairy heifers, but is
not considered a significant disease in mature dairy cows. |
|
Level of Drug: |
Monensin activity 22 mg/kg (0.0022%) in the complete diet. |
|
NOTE: |
Complete diet refers to the complete feed plus the roughage and must be
corrected to a 100% dry matter basis. |
|
Directions for use: |
At a level in supplements, premixes, and complete feeds so that when used
as directed, the approved level of drug will be supplied. Thoroughly mix supplements
and premixes in the total daily diet or in complete feed (grain portion of the ration)
before use. Do not feed undiluted.
Medicated supplement/premix fed as a % of total diet dry matter:
Mixing medicated supplements or premixes as a % of total diet dry matter is ideal. The
following calculation can be used to assist in determining the amount of monensin sodium
required per kg of supplement/premix dry matter to meet the approved level of drug in the
total diet dry matter;
mg monensin/kg supplement/premix dry matter = (approved drug level (mg/kg total diet
Dry Matter)) / (% inclusion of supplement/premix into diet on a 100% dry matter basis) x
100
Medicated supplement/premix fed as a fixed amount/ head/ day:
It may sometimes be preferable to mix the medicated supplement/premix in the complete feed
or total diet as a fixed amount/head/day. The approved levels of monensin sodium must be
converted to mg/head/day to accommodate this type of feeding. To do this, the following
calculation is used:
mg/head/day = weight of animal (kg) x dry matter intake (% of body weight) x approved
drug level (mg/kg total diet Dry Matter).
This calculation has been made for a wide range of body weights, using six different
dry matter intake levels and is presented in "Daily Intake of Monensin Activity"
tables found in the Rumensin Technical Reference Guide Addendum, or is available from the
manufacturer in the case of Monensin Premix.
Note that feed labels will be required to state both the body weight of the
cattle being fed as well as their dry matter intake.
Medicated complete feeds:
Medicated complete feeds are often fed separately from the forage part of the ration on a
fixed amount/head/day. The approved levels of monensin sodium must be converted to mg/head/day
to accommodate this type of feeding. To do this, the following calculation is used:
mg monensin/head/day = weight of animal (kg) x dry matter intake (as a % of body
weight) x approved drug level (mg/kg total diet Dry Matter).
Note that feed labels will be required to state both the body weight of the
cattle being fed as well as their dry matter intake. |
|
NOTE: |
Rumensin Premix and COBAN Premix only can be used in the following
thixotrope liquid supplements:
1) HCS, Nutrena Feeds, Cargill Limited;
2) Promolas Liquid Supplement Suspension, Westway Feed Products, a Division of
Westway Holdings Canada Inc. |
|
WARNING: |
1. Do not supplement monensin from other sources (eg. other feedstuffs
containing monensin or the Rumensin Controlled Release Capsule). |
|
CAUTION: |
1. Do not exceed recommended levels as reduced average daily gains may
result. 2. Do not allow dogs, horses, other equines or guinea fowl access to
formulations containing monensin. Ingestion of monensin by these species has been fatal.
3. Do not use monensin- medicated feed for the treatment of outbreaks of coccidiosis.
4. May be used in feeds containing the pellet-binding agents Bentonite (2%),
Attapulgite (2%), Kaolin (2.5%), Lignin Sulfonate(4%), Carboxymethylcellulose (0.1%), or
Agri-Colloid. (Premix and supplement labels only).
5. Do not use thixotropic supplements after four weeks storage. (Cargill thixotropic
liquid supplement labels only).
6. Do not use thixotropic supplements after eight weeks storage. (Westway Feed
Products, A Division of Westway Holdings Canada Inc., thixotropic liquid supplement labels
only). |
| Claim 5: |
For increased rate of weight gain in growing cattle on
pasture (slaughter, stocker and feeder cattle, and beef and dairy replacement heifers) of
greater than 180 kg (400 lb) body weight. |
|
Level of drug: |
200 mg of monensin activity per head per day. |
|
Directions: |
Hand feed continuously a minimum of 0.5 kg of medicated supplement per day to supply
200 mg of monensin activity per head per day. The medicated supplement must be hand fed
from the beginning to the end of the pasture season. |
|
NOTE: |
Thixotrope liquid medicated supplements should not be used for hand feeding
of cattle on pasture. |
|
WARNING: |
1. Do not supplement monensin from other sources (eg. other feed stuffs
containing monensin or the Rumensin Controlled Release Capsule). |
|
CAUTION: |
1. Do not exceed recommended levels as reduced average daily gains may
result. 2. Do not allow dogs, horses or other equines or guinea fowl access to
formulations containing monensin. Ingestion of monensin by these species has been fatal.
3. Do not use monensin-medicated feed for the treatment of outbreaks of coccidiosis.
4. May be used in feeds containing the pellet-binding agents Bentonite (2%),
Attapulgite (2%), Kaolin (2.5%), Lignin Sulfonate (4%), Carboxymethylcellulose (0.1%), or
Agri-Colloid. (Premix and Supplement labels only). |
| Claim 6: |
For reduction of milk fat percentage in lactating dairy
cows. |
|
NOTE: |
The expected efficacy of this product for reduction of milk fat percentage
may be affected by dietary factors. Reduced efficacy may be expected with diets higher in
fibre or lower in unsaturated oils. |
|
Level of drug: |
Monensin activity 16 mg/kg - 24 mg/kg (0.0016%-0.0024%) in the complete
diet. |
|
NOTE: |
1. Feed labels must state one specific drug level. |
|
|
2. Complete diet refers to the complete feed plus the roughage and must be
corrected to a 100% dry matter basis. |
|
Directions: |
At a level in supplements, premixes, and complete feeds so that when used as directed,
the approved level of drug will be supplied. Thoroughly mix supplements and premixes in
the total daily diet or in complete feed (grain portion of the ration) before use. Do not
feed undiluted.
Medicated supplement/premix fed as a % of total diet dry matter:
Mixing medicated supplements or premixes as a % of total diet dry matter is ideal. The
following calculation can be used to assist in determining the amount of monensin sodium
required per kg of supplement/premix dry matter to meet the approved level of drug in the
total diet dry matter;
mg monensin/kg supplement/premix dry matter = (approved drug level (mg/kg total diet
Dry Matter)) / (% inclusion of supplement/premix into diet on a 100% dry matter basis) x
100
Medicated supplement/premix fed as a fixed amount/ head/ day:
It may sometimes be preferable to mix the medicated supplement/premix in the complete
feed or total diet as a fixed amount/head/day. The approved levels of monensin sodium must
be converted to mg/head/day to accommodate this type of feeding. To do this, the following
calculation is used:
mg/head/day = weight of animal (kg) x dry matter intake (% of body weight) x approved
drug level (mg/kg total diet Dry Matter).
This calculation has been made for a wide range of body weights, using six different
dry matter intake levels and is presented in "Daily Intake of Monensin Activity"
tables found in the Rumensin Technical Reference Guide Addendum.
Note that feed labels will be required to state both the body weight of the
cattle being fed as well as their dry matter intake.
Medicated complete feeds:
Medicated complete feeds are often fed separately from the forage part of the ration on
a fixed amount/head/day. The approved levels of monensin sodium must be converted to mg/head/day
to accommodate this type of feeding. To do this, the following calculation is used:
mg monensin/head/day = weight of animal (kg) x dry matter intake (as a % of body
weight) x approved drug level (mg/kg total diet Dry Matter).
Note that feed labels will be required to state both the body weight of the
cattle being fed as well as their dry matter intake. |
|
NOTE: |
Rumensin Premix and COBAN Premix only can be used in the following
thixotrope liquid supplements:
1) HCS, Nutrena Feeds, Cargill Limited;
2) Promolas Liquid Supplement Suspension, Westway Feed Products, a Division of
Westway Holdings Canada Inc. |
|
WARNING: |
1. Do not supplement monensin from other sources (eg. other feed stuffs
containing monensin or the Rumensin Controlled Release Capsule). |
|
CAUTION: |
1. Do not allow dogs, horses, other equines or guinea fowl access to
formulations containing monensin. Ingestion of monensin by these species has been fatal. 2.
May be used in feeds containing the pellet-binding agents Bentonite (2%), Attapulgite
(2%), Kaolin (2.5%), Lignin Sulfonate(4%), Carboxymethylcellulose (0.1%), or Agri-Colloid.
(Premix and supplement labels only).
3. Do not use thixotropic supplements after four weeks storage. (Cargill thixotropic
liquid supplement labels only).
4. Do not use thixotropic supplements after eight weeks storage. (Westway Feed
Products, A Division of Westway Holdings Canada Inc., thixotropic liquid supplement labels
only).
5. The 24 g/tonne monensin treatment in primiparous cows may result in the increased
incidence of udder edema and increased number of inseminations per full term conception.
6. The continuous use of monensin in dairy cows may be associated with increased rates
of twinning and stillbirths, and heavier birth weights for heifer calves. |
| Claim 7: |
For minimizing loss of body condition during lactation in
dairy cows. |
|
Level of drug: |
Monensin activity 8 mg/kg - 24 mg/kg (0.0008%-0.0024%) in the complete
diet. |
|
NOTE: |
1. Feed labels must state one specific drug level. |
|
|
2. Complete diet refers to the complete feed plus the roughage and must be
corrected to a 100% dry matter basis. |
|
Directions: |
At a level in supplements, premixes, and complete feeds so that when used as directed,
the approved level of drug will be supplied. Thoroughly mix supplements and premixes in
the total daily diet or in complete feed (grain portion of the ration) before use. Do not
feed undiluted.
Medicated supplement/premix fed as a % of total diet dry matter:
Mixing medicated supplements or premixes as a % of total diet dry matter is ideal. The
following calculation can be used to assist in determining the amount of monensin sodium
required per kg of supplement/premix dry matter to meet the approved level of drug in the
total diet dry matter;
mg monensin/kg supplement/premix dry matter = (approved drug level (mg/kg total diet
Dry Matter)) / (% inclusion of supplement/premix into diet on a 100% dry matter basis) x
100
Medicated supplement/premix fed as a fixed amount/ head/ day:
It may sometimes be preferable to mix the medicated supplement/premix in the complete
feed or total diet as a fixed amount/head/day. The approved levels of monensin sodium must
be converted to mg/head/day to accommodate this type of feeding. To do this, the following
calculation is used:
mg/head/day = weight of animal (kg) x dry matter intake (% of body weight) x approved
drug level (mg/kg total diet Dry Matter).
This calculation has been made for a wide range of body weights, using six different
dry matter intake levels and is presented in "Daily Intake of Monensin Activity"
tables found in the Rumensin Technical Reference Guide Addendum.
Note that feed labels will be required to state both the body weight of the
cattle being fed as well as their dry matter intake.
Medicated complete feeds:
Medicated complete feeds are often fed separately from the forage part of the ration on
a fixed amount/head/day. The approved levels of monensin sodium must be converted to mg/head/day
to accommodate this type of feeding. To do this, the following calculation is used:
mg monensin/head/day = weight of animal (kg) x dry matter intake (as a % of body
weight) x approved drug level (mg/kg total diet Dry Matter)
Note that feed labels will be required to state both the body weight of the
cattle being fed as well as their dry matter intake. |
|
NOTE: |
Rumensin Premix and COBAN Premix only can be used in the following
thixotrope liquid supplements:
1) HCS, Nutrena Feeds, Cargill Limited;
2) Promolas Liquid Supplement Suspension, Westway Feed Products, a Division of
Westway Holdings Canada Inc. |
|
WARNING: |
1. Do not supplement monensin from other sources (eg. other feed stuffs
containing monensin or the Rumensin Controlled Release Capsule). |
|
CAUTION: |
1. Do not allow dogs, horses, other equines or guinea fowl access to
formulations containing monensin. Ingestion of monensin by these species has been fatal. 2.
May be used in feeds containing the pellet-binding agents Bentonite (2%), Attapulgite
(2%), Kaolin (2.5%), Lignin Sulfonate(4%), Carboxymethylcellulose (0.1%), or Agri-Colloid.
(Premix and supplement labels only).
3. Do not use thixotropic supplements after four weeks storage. (Cargill thixotropic
liquid supplement labels only).
4. Do not use thixotropic supplements after eight weeks storage. (Westway Feed
Products, A Division of Westway Holdings Canada Inc., thixotropic liquid supplement labels
only)..
5. The 24 g/tonne monensin treatment in primiparous cows may result in the increased
incidence of udder edema and increased number of inseminations per full term conception.
6. The continuous use of monensin in dairy cows may be associated with increased rates
of twinning and stillbirths, and heavier birth weights for heifer calves. |
| Claim 8: |
For improving feed efficiency of milk protein production in
lactating dairy cows. |
|
Level of drug: |
Monensin activity 16 mg/kg - 24 mg/kg (0.0016%-0.0024%) in the complete
diet. |
|
NOTE: |
1. Feed labels must state one specific drug level. |
|
|
2. Complete diet refers to the complete feed plus the roughage and must be
corrected to a 100% dry matter basis. |
|
Directions: |
At a level in supplements, premixes, and complete feeds so that when used as directed,
the approved level of drug will be supplied. Thoroughly mix supplements and premixes in
the total daily diet or in complete feed (grain portion of the ration) before use. Do not
feed undiluted.
Medicated supplement/premix fed as a % of total diet dry matter:
Mixing medicated supplements or premixes as a % of total diet dry matter is ideal. The
following calculation can be used to assist in determining the amount of monensin sodium
required per kg of supplement/premix dry matter to meet the approved level of drug in the
total diet dry matter;
mg monensin/kg supplement/premix dry matter = (approved drug level (mg/kg total diet
Dry Matter)) / (% inclusion of supplement/premix into diet on a 100% dry matter basis) x
100
Medicated supplement/premix fed as a fixed amount/ head/ day:
It may sometimes be preferable to mix the medicated supplement/premix in the complete
feed or total diet as a fixed amount/head/day. The approved levels of monensin sodium must
be converted to mg/head/day to accommodate this type of feeding. To do this, the following
calculation is used:
mg/head/day = weight of animal (kg) x dry matter intake (% of body weight) x approved
drug level (mg/kg total diet Dry Matter).
This calculation has been made for a wide range of body weights, using six different
dry matter intake levels and is presented in "Daily Intake of Monensin Activity"
tables found in the Rumensin Technical Reference Guide Addendum.
Note that feed labels will be required to state both the body weight of the
cattle being fed as well as their dry matter intake.
Medicated complete feeds:
Medicated complete feeds are often fed separately from the forage part of the ration on
a fixed amount/head/day. The approved levels of monensin sodium must be converted to mg/head/day
to accommodate this type of feeding. To do this, the following calculation is used:
mg monensin/head/day = weight of animal (kg) x dry matter intake (as a % of body
weight) x approved drug level (mg/kg total diet Dry Matter).
Note that feed labels will be required to state both the body weight of the
cattle being fed as well as their dry matter intake. |
|
NOTE: |
Rumensin Premix and COBAN Premix only can be used in the following
thixotrope liquid supplements:
1) HCS, Nutrena Feeds, Cargill Limited;
2) Promolas Liquid Supplement Suspension, Westway Feed Products, a Division of
Westway Holdings Canada Inc. |
|
WARNING: |
1. Do not supplement monensin from other sources (eg. other feed stuffs
containing monensin or the Rumensin Controlled Release Capsule). |
|
CAUTION: |
1. Do not allow dogs, horses, other equines or guinea fowl access to
formulations containing monensin. Ingestion of monensin by these species has been fatal. 2.
May be used in feeds containing the pellet-binding agents Bentonite (2%), Attapulgite
(2%), Kaolin (2.5%), Lignin Sulfonate(4%), Carboxymethylcellulose (0.1%), or Agri-Colloid.
(Premix and supplement labels only).
3. Do not use thixotropic supplements after four weeks storage. (Cargill thixotropic
liquid supplement labels only).
4. Do not use thixotropic supplements after eight weeks storage. (Westway Feed
Products, A Division of Westway Holdings Canada Inc., thixotropic liquid supplement labels
only).
5. The 24 g/tonne monensin treatment in primiparous cows may result in the increased
incidence of udder edema and increased number of inseminations per full term conception.
6. The continuous use of monensin in dairy cows may be associated with increased rates
of twinning and stillbirths, and heavier birth weights for heifer calves. |
